These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7724539)

  • 1. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.
    Naffakh N; Henri A; Villeval JL; Rouyer-Fessard P; Moullier P; Blumenfeld N; Danos O; Vainchenker W; Heard JM; Beuzard Y
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3194-8. PubMed ID: 7724539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of erythropoietin delivery from engineered muscles in mice.
    Bohl D; Heard JM
    Hum Gene Ther; 1997 Jan; 8(2):195-204. PubMed ID: 9017423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids direct systemic expression of erythropoietin in mice.
    Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ
    Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.
    Schwenter F; Déglon N; Aebischer P
    J Gene Med; 2003 Mar; 5(3):246-57. PubMed ID: 12666190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
    Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
    Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-immunomodulating myoblast cell line for erythropoietin delivery.
    Schneider BL; Peduto G; Aebischer P
    Gene Ther; 2001 Jan; 8(1):58-66. PubMed ID: 11402302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts.
    Scheidemann F; Löser M; Niedermeier A; Kromminga A; Therrien JP; Vogel J; Pfützner W
    Exp Dermatol; 2008 Jun; 17(6):481-8. PubMed ID: 18331333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells.
    Serguera C; Bohl D; Rolland E; Prevost P; Heard JM
    Hum Gene Ther; 1999 Feb; 10(3):375-83. PubMed ID: 10048390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for long-term expression of erythropoietin in rats.
    Osborne WR; Ramesh N; Lau S; Clowes MM; Dale DC; Clowes AW
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8055-8. PubMed ID: 7644537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia.
    Villeval JL; Rouyer-Fessard P; Blumenfeld N; Henri A; Vainchenker W; Beuzard Y
    Blood; 1994 Aug; 84(3):928-33. PubMed ID: 8043875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.
    Hamamori Y; Samal B; Tian J; Kedes L
    J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.
    Hamamori Y; Samal B; Tian J; Kedes L
    Hum Gene Ther; 1994 Nov; 5(11):1349-56. PubMed ID: 7893806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
    Eliopoulos N; Lejeune L; Martineau D; Galipeau J
    Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts.
    Moullier P; Maréchal V; Danos O; Heard JM
    Transplantation; 1993 Aug; 56(2):427-32. PubMed ID: 8356601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts.
    Sommer B; Rinsch C; Payen E; Dalle B; Schneider B; Déglon N; Henri A; Beuzard Y; Aebischer P
    Mol Ther; 2002 Aug; 6(2):155-61. PubMed ID: 12161181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.
    Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM
    Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of transgenic fibroblasts for producing recombinant human interferon-α and erythropoietin in bovine milk.
    Jung EM; An BS; Kim YK; Hwang I; Lee JY; Shin TY; Hyun SH; Hwang WS; Jeung EB
    Mol Med Rep; 2013 Feb; 7(2):406-12. PubMed ID: 23151730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainable systemic delivery via a single injection of lentivirus into human skin tissue.
    Baek SC; Lin Q; Robbins PB; Fan H; Khavari PA
    Hum Gene Ther; 2001 Aug; 12(12):1551-8. PubMed ID: 11506697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo.
    Dalle B; Henri A; Rouyer-Fessard P; Bettan M; Scherman D; Beuzard Y; Payen E
    Blood; 2001 Jun; 97(12):3776-82. PubMed ID: 11389016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.